CUBERES-ALTISENT, MARIA ROSA,SOLA-CARANDELL, LLUIS,GARCIA-COUCEIRO, URKO
申请号：
CA2781744
公开号：
CA2781744C
申请日:
2010.11.25
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to 4-[-2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3- yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.
